/ 100
Novartis India (NOVARTIND) — Technical Setup
₹2,047 -1.70% Strong Uptrend Volatility Expansion Neutral
Summary
Novartis India is in a strong uptrend on the daily chart. RSI(14) is 59.0, MACD is above its signal line, ADX reads 37 (trending). Volume in the latest session was 0.3× its 20-day average. Over three months it has outperformed the Nifty 50 by 41.0 percentage points. Nearest support is ₹1,702.30 and resistance ₹2,588.80. Its technical score is 56/100 (neutral).
🧮 How the 56/100 is built
Five components, 20 points each. Every rule is shown with the points it earned — the score describes the chart as it stands today; it is not a prediction.
- Close above 20-day EMA (6.60)3/3
- 20-day EMA above 50-day EMA3/3
- 50-day EMA above 200-day EMA0/3
- Close above 200-day SMA0/3
- SuperTrend (10,3) pointing up3/3
- ADX ≥ 20 with +DI above −DI (trend has strength) (36.55)3/3
- Weekly trend up (above a rising 30-week average)0/2
- RSI(14) in the bullish zone (55-70 best) (59.05)6/6
- MACD line above its signal line4/4
- MACD line above zero (160.45)3/3
- 12-day rate of change positive (27.81)3/3
- Stochastic %K above %D0/2
- Outperforming the Nifty 50 over 3 months (41.04)2/2
- On-balance volume rising over 20 sessions5/5
- Chaikin Money Flow (20) positive (0.23)5/5
- More volume on up days than down days (20 sessions) (4.49)5/5
- Close above 20-day VWAP (-7.64)0/5
- Daily range (ATR%) contained — ≤2.5% scores full (6.92)0/6
- Price in the upper half of its Bollinger Bands (0.66)5/5
- Shallow drawdown from the 52-week high (-20.94)1/5
- Volatility contracting (20-day volatility below its 6-month median) (94.50)0/4
- Room to the next resistance (≥8% scores full) (26.48)5/5
- Support close below (a tight, definable stop) (16.83)0/5
- Broke above a 20-day high in the last 5 sessions0/5
- Within 5% of the 52-week high (-20.94)0/5
🧭 Regime: Strong Uptrend
Volatility Expansion — Bollinger width is in the 96th percentile of the last six months.
Suits: Trend-following. Pullbacks to the 20-day EMA and breakouts tend to be bought in strong trends; mean-reversion shorts fight the tape.
Classified from ADX, the 20/50-day EMA stack and price's distance from the 50-day average; volatility from band-width and ATR expansion.
Opens the AI Backtester with the Momentum Breakout rules for NOVARTIND — close at a 20-day high on 1.5× average volume, rsi above 55.
🕰️ Multi-timeframe
| Timeframe | Trend | RSI (14) | MACD hist. |
|---|---|---|---|
| Monthly | — | — | — |
| Weekly | — | — | — |
| Daily | ▲ Bullish | 59.05 | 20.94 |
Weekly: close vs a rising 30-week average (Weinstein). Monthly: close vs the 10-month average. Weekly SuperTrend: —, weekly ADX —.
📶 Volume & VWAP
VWAPs are computed from daily bars (typical price × volume), not intraday ticks. Volume has dried up to under 60% of normal.
💪 Relative strength
NOVARTIND ÷ Nifty 50, rebased to 100 a year ago. Rising = outperforming.
🧱 Support & resistance
Clustered swing highs and lows from the last year; “touches” is how many swings formed the level.
| Level | Price | Distance | Touches |
|---|---|---|---|
| Resistance | ₹2,588.80 | +26.5% | 1 |
| Close | ₹2,047 | — | |
| Support | ₹1,702.30 | −16.8% | 4 |
| Support | ₹1,546.30 | −24.4% | 4 |
| Support | ₹1,411.55 | −31.0% | 2 |
| Support | ₹1,275.00 | −37.7% | 3 |
52-week range: ₹672.25 – ₹2,589 (-20.94% from the high).
🌀 Fibonacci
Measuring the up-swing from ₹672.25 (2026-04-15) to ₹2,588.80 (2026-09-10). Price has retraced 28.3% of it.
| Ratio | Price | Distance | |
|---|---|---|---|
| 23.6% retracement | ₹2,136.49 | +4.4% | nearest |
| 38.2% retracement | ₹1,856.68 | -9.3% | |
| 50.0% retracement | ₹1,630.53 | -20.3% | |
| 61.8% retracement | ₹1,404.37 | -31.4% | S/R confluence |
| 78.6% retracement | ₹1,082.39 | -47.1% | |
| 127.2% extension | ₹3,110.10 | +52.0% | |
| 161.8% extension | ₹3,773.23 | +84.3% | |
| 200.0% extension | ₹4,505.35 | +120.1% |
🕯️ Candlesticks (last 5 sessions)
- Shooting Star 2026-09-17 bearish Moderate · 50
Quality combines the pattern's reliability with its context: prior trend, volume, a support/resistance level and RSI.
↗️ Divergences
No regular divergence on RSI, MACD, OBV, MFI or Stochastic at the latest swings.
✅ Screens NOVARTIND passes today
| Stock | Close | Chg | Score | Trend regime | RS rating (1-99) |
|---|---|---|---|---|---|
| AUROPHARMAAurobindo Pharma Limited | ₹1,734 | +2.60% | 94 | Uptrend | 84.00 |
| AAREYDRUGSAarey Drugs & Pharmaceuticals Limited | ₹102.13 | +0.40% | 85 | Strong Uptrend | 86.00 |
| ACUTAASAcutaas Chemicals Limited | ₹3,440 | +3.78% | 85 | Uptrend | 93.00 |
| KOPRANKopran Limited | ₹277.60 | +3.35% | 85 | Strong Uptrend | 96.00 |
| BAFNAPHBafna Pharmaceuticals Limited | ₹317.20 | +1.99% | 84 | Strong Uptrend | 98.00 |
| KILITCHKilitch Drugs (India) Limited | ₹191.45 | +1.47% | 84 | Uptrend | 63.00 |
| CAPLIPOINTCaplin Point Laboratories Limited | ₹2,749 | +5.85% | 83 | Uptrend | 83.00 |
| GLANDGland Pharma Limited | ₹2,962 | +1.86% | 83 | Strong Uptrend | 91.00 |
| JUBLPHARMAJubilant Pharmova Limited | ₹1,065 | +5.27% | 80 | Strong Uptrend | 64.00 |
| STARStrides Pharma Science Limited | ₹1,220 | +1.63% | 80 | Strong Uptrend | 81.00 |
⚠️ Educational technical analysis computed automatically from end-of-day NSE prices — not investment advice. Flash Finance is not SEBI-registered. Indicators describe what price has done; they do not predict what it will do. Verify levels on a live chart and manage risk before acting.
